Filter News
Area of Research
- (-) Neutron Science (14)
- Advanced Manufacturing (3)
- Biology and Environment (14)
- Clean Energy (26)
- Computational Engineering (1)
- Computer Science (2)
- Energy Frontier Research Centers (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (11)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (34)
- Materials for Computing (3)
- National Security (16)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (29)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (4)
- (-) Cybersecurity (1)
- (-) Microscopy (1)
- (-) Nanotechnology (6)
- (-) Nuclear Energy (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (3)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (2)
- Environment (3)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- National Security (1)
- Neutron Science (40)
- Physics (7)
- Quantum Science (4)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
Five researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
A team led by the Department of Energy’s Oak Ridge National Laboratory synthesized a tiny structure with high surface area and discovered how its unique architecture drives ions across interfaces to transport energy or information.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.